Article
Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour - A Methodological Assessment Study.
Anticancer research - 1 Nov 2022
Brinch Charlotte Margareta, Aggerholm-Pedersen Ninna, Poulsen Tim Svenstrup, Skovrider-Ruminski Wojciech, DE Heer Pieter, Penninga Luit, Krarup-Hansen Anders, Hogdall Estrid
Abstract excerpt
BACKGROUND/AIM: Gastrointestinal stromal tumours (GISTs) harbour genetic aberrations in receptor tyrosine kinase KIT (KIT) or platelet-derived growth factor receptor A (PDGFRA) in 85-90% of the patients. Circulating tumour DNA (ctDNA) is a potential biomarker in patients with GIST. Previous studies investigating ctDNA around surgery in patients with GIST presented divergent results regarding the proportion of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
